BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Calcitonin salmon | Calcitonin salmon, a calcium regulating hormone, has been shown to be an effective alternative for the treatment of postmenopausal osteoporosis. Alternative Names: Salmon calcitonin; H-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2 (Disulfide bridge: Cys1-Cys7); L-cysteinyl-L-seryl-L-asparagyl-L-leucyl-L-seryl-L-threonyl-L-cysteinyl-L-valyl-L-leucyl-glycyl-L-lysyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L-glutaminyl-L-threonyl-L-tyrosyl-L-prolyl-L-arginyl-L-threonyl-L-asparagyl-L-threonyl-glycyl-L-seryl-glycyl-L-threonyl-L-prolinamide (1->7)-disulfide; Calciben; Calcimar; Calcitonin (salmon reduced), cyclic (1→7)-disulfide; Calsyn; Calsynar; Catonin; Karil; Miacalcic; Miacalcin; Miadenil; Prontocalcin; Rulicalcin; Salcatonin; Salmon calcitonin; Salmon calcitonin I; Salmon calcitonin-(1-32); Salmon Thyrocalcitonin; Salmotonin; SMC 021 A/C; Stalcin; Tonocalcin. Grades: 98%. CAS No. 47931-85-1. Molecular formula: C145H240N44O48S2. Mole weight: 3431.85. |  |
| Callinectin | Callinectin is an antibacterial Peptide from Blue Crab. | |
| Calmodulin (58-70) | Calmodulin (58-70) is a fragment of Calmodulin, a calcium-binding protein found in the cytoplasm of all eukaryotic cells. It interacts with many other proteins in the cell, and acts as a regulator or an effector molecule in a wide variety of cellular functions. These functions include things as diverse as regulation of the cell cycle, intracellular signalling, fertilization, and muscle contraction. | |
| Calmodulin Binding Peptide 1 | Calmodulin Binding Peptide 1, a high affinity (pM) CaM-Binding Peptide derived from smooth muscle myosin light chain kinase (MLCK) Peptide, strongly inhibits IP3-induced Ca2+ release. Alternative Names: Gly-Val-Met-Pro-Arg-Glu-Glu-Thr-Asp-Ser-Lys-Thr-Ala-Ser-Pro-Trp-Lys-Ser-Ala-Arg-Leu-Met-Val-His-Thr-Val-Ala-Thr-Phe-Asn-Ser-Ile-Lys-Glu-Leu-Asn-Glu-Arg-Trp-Arg-Ser-Leu-Gln-Gln-Leu-Ala. Grades: ≥95%. CAS No. 104041-80-7. Molecular formula: C231H373N69O70S2. Mole weight: 5300.97. | |
| Calmodulin-Dependent Protein Kinase II 281-309 | Calmodulin-Dependent Protein Kinase II 281-309 is the 281-309 amino acid fragment of calcium / calmodulin-dependent protein kinase II (CAM-kinase II). Alternative Names: Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala; CAM-kinase II 281-309. Grades: ≥95%. CAS No. 116826-37-0. Molecular formula: C146H254N46O39S3. Mole weight: 3374.06. | |
| Calmodulin-Dependent Protein Kinase II 290-309 | Calmodulin-dependent protein kinase II (290-309) is a synthetic peptide derived from the rat brain protein sequence that contains the calmodulin binding domain. It inhibits calcium / calmodulin-dependent protein kinase II (CaMKII) with IC50 of 52 nM and CaMKII-dependent phosphodiesterase activity with IC50 of 1.1 nM. It has been used in the study of CaM binding, autophosphorylatio and dynamics. Alternative Names: Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala; L-leucyl-L-lysyl-L-lysyl-L-phenylalanyl-L-asparagyl-L-alanyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-lysyl-glycyl-L-alanyl-L-isoleucyl-L-leucyl-L-threonyl-L-threonyl-L-methionyl-L-leucyl-L-alanine; CaM kinase II (290-309); Calmodulin-dependent Protein Kinase II fragment 290-309. Grades: ≥97% by HPLC. CAS No. 115044-69-4. Molecular formula: C103H185N31O24S. Mole weight: 2273.83. | |
| Caloxin 2A1 | Caloxin 2A1 is a selective extracellular peptide inhibitor of the plasma membrane Ca2+-ATPase (PMCA). It has no effect on basic Mg2+-ATPase or Na+-K+-ATPase. Alternative Names: H-Val-Ser-Asn-Ser-Asn-Trp-Pro-Ser-Phe-Pro-Ser-Ser-Gly-Gly-Gly-NH2; L-valyl-L-seryl-L-asparagyl-L-seryl-L-asparagyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-seryl-glycyl-glycyl-glycinamide; Glycinamide, L-valyl-L-seryl-L-asparaginyl-L-seryl-L-asparaginyl-L-tryptophyl-L-prolyl-L-seryl-L-phenylalanyl-L-prolyl-L-seryl-L-serylglycylglycyl-. Grades: ≥95%. CAS No. 350670-85-8. Molecular formula: C64H91N19O22. Mole weight: 1478.54. | |
| CALP2 | CALP2 is a cell-permeable calmodulin (CaM) antagonist binding to the EF-hand/Ca2+-binding site. CALP2 exhibits an inhibitory effect on CaM-dependant phosphodiesterase activity, and leads to an increase on intracellular Ca2+ level by modulating Ca2+-channel activity. CALP2 was also shown to be a potent activator of alveolar macrophages. Alternative Names: Calcium-like peptide 2. CAS No. 261969-04-4. Molecular formula: C68H104N14O13S. Mole weight: 1357.72. | |
| CALP3 | CALP3 is a cell-permeable calmodulin (CaM) agonist binding to the EF-hand/Ca2+-binding site. It activates phosphodiesterase in the absence of Ca2+ and suppresses Ca2+-mediated cytotoxicity and apoptosis (IC50 = 33 μM). Alternative Names: Calcium-like peptide 3. CAS No. 261969-05-5. Molecular formula: C44H68N10O9. Mole weight: 881.08. | |
| CALP3 acetate | CALP3 acetate is a potent Ca2+ channel blocker that mimics [Ca2+]i increase by regulating the activity of calmodulin (CaM), Ca2+ channels, and pumps. CALP3 is a cell-permeable calmodulin (CaM) agonist binding to the EF-hand/Ca2+-binding site. Alternative Names: H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH.CH3CO2H; L-valyl-L-lysyl-L-phenylalanyl-glycyl-L-valyl-glycyl-L-phenylalanyl-L-lysine acetic acid; CALP 3 acetate; CALP-3 acetate; Calcium-like peptide 3 acetate. Grades: ≥95%. Molecular formula: C46H72N10O11. Mole weight: 941.12. | |
| CALP3 trifluoroacetate salt | CALP3 is a calcium-like peptide that contains the first eight residues of CALP2, which is a 12-residue peptide that interacts with EF hand motif 4 in human calmodulin to activate it in the absence of calcium. It acts as a cell-permeable inhibitor of calcium influx through glutamate receptor channels in cultured rat neocortical neurons with IC50 of 37.25 μM. It also inhibits excitatory cytotoxicity with IC50 of 50.97 μM and apoptosis with IC50 of 33.41 μM. CALP3 was used to study as a new type of Ca2+ channel blocker that targets Ca2+ sensors and prevents Ca2+-mediated apoptosis. Alternative Names: H-Val-Lys-Phe-Gly-Val-Gly-Phe-Lys-OH.TFA; L-valyl-L-lysyl-L-phenylalanyl-glycyl-L-valyl-glycyl-L-phenylalanyl-L-lysine trifluoroacetate; CALP 3 trifluoroacetate; CALP-3 trifluoroacetate; CALP3 TFA; CALP 3 TFA; CALP-3 TFA; Calcium-like peptide 3 TFA. Grades: ≥98%. Molecular formula: C46H69F3N10O11. Mole weight: 995.11. | |
| Camstatin | Camstatin, an analog of PEP-19, has been found to have enhanced activities binding to and antagonism of calmodulin. Alternative Names: Camstatin; 1002295-95-5; AKOS024458712; PD078973; S-1002295-95-5. Grades: ≥95% by HPLC. CAS No. 1002295-95-5. Molecular formula: C122H203N39O34. Mole weight: 2760.19. | |
| Cancer related antigens BST-2 (126-134) | Cancer related antigens BST-2 (126-134) is a peptide corresponding to residues 126-134 of BST-2. BST-2 is a unique innate immunity gene with both antiviral and pro-tumor functions and therefore can serve as a paradigm for understanding the roles of other innate immunity genes in cancers. Alternative Names: Cancer related antigens Bone marrow stromal antigen 2 (126-134). | |
| Cancer / testis antigen 1 (119-138) | Cancer / testis antigen 1 (119-138) is a 20-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (119-138); Cancer / testis antigen 6.1 (119-138); L antigen family member 2 (119-138). | |
| Cancer / testis antigen 1 (119-143) | Cancer / testis antigen 1 (119-143) is a 25-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (119-143); Cancer / testis antigen 6.1 (119-143); L antigen family member 2 (119-143). | |
| Cancer / testis antigen 1 (121-130) | Cancer / testis antigen 1 (121-130) is a 10-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (121-130); Cancer / testis antigen 6.1 (121-130); L antigen family member 2 (121-130). | |
| Cancer / testis antigen 1 (123-137) | Cancer / testis antigen 1 (123-137) is a 15-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (123-137); Cancer / testis antigen 6.1 (123-137); L antigen family member 2 (123-137). | |
| Cancer / testis antigen 1 (124-134) | Cancer / testis antigen 1 (124-134) is a 11-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (124-134); Cancer / testis antigen 6.1 (124-134); L antigen family member 2 (124-134). | |
| Cancer / testis antigen 1 (124-135) | Cancer / testis antigen 1 (124-135) is a 12-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (124-135); Cancer / testis antigen 6.1 (124-135); L antigen family member 2 (124-135). | |
| Cancer / testis antigen 1 (127-136) | Cancer / testis antigen 1 (127-136) is a 10-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (127-136); Cancer / testis antigen 6.1 (127-136); L antigen family member 2 (127-136). | |
| Cancer / testis antigen 1 (139-156) | Cancer / testis antigen 1 (139-156) is a 18-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (139-156); Cancer / testis antigen 6.1 (139-156); L antigen family member 2 (139-156). | |
| Cancer / testis antigen 1 (53-62) | Cancer / testis antigen 1 (53-62) is a 10-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (53-62); Cancer / testis antigen 6.1 (53-62); L antigen family member 2 (53-62). | |
| Cancer / testis antigen 1 (60-72) | Cancer / testis antigen 1 (60-72) is a 13-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (60-72); Cancer / testis antigen 6.1 (60-72); L antigen family member 2 (60-72). | |
| Cancer / testis antigen 1 (80-88) | Cancer / testis antigen 1 (80-88) is a 9-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (80-88); Cancer / testis antigen 6.1 (80-88); L antigen family member 2 (80-88). | |
| Cancer / testis antigen 1 (86-97) | Cancer / testis antigen 1 (86-97) is a 12-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (86-97); Cancer / testis antigen 6.1 (86-97); L antigen family member 2 (86-97). | |
| Cancer / testis antigen 1 (87-100) | Cancer / testis antigen 1 (87-100) is a 14-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (87-100); Cancer / testis antigen 6.1(87-100); L antigen family member 2 (87-100). | |
| Cancer / testis antigen 1 (87-111) | Cancer / testis antigen 1 (87-111) is a 25-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (87-111); Cancer / testis antigen 6.1 (87-111); L antigen family member 2 (87-111). | |
| Cancer / testis antigen 1 (89-100) | Cancer / testis antigen 1 (89-100) is a 12-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (89-100); Cancer / testis antigen 6.1 (89-100); L antigen family member 2 (89-100). | |
| Cancer / testis antigen 1 (91-101) | Cancer / testis antigen 1 (91-101) is a 11-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (91-101); Cancer / testis antigen 6.1 (91-101); L antigen family member 2 (91-101). | |
| Cancer / testis antigen 1 (92-100) | Cancer / testis antigen 1 (92-100) is a 9-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (92-100); Cancer / testis antigen 6.1 (92-100); L antigen family member 2 (92-100). | |
| Cancer / testis antigen 1 (94-102) | Cancer / testis antigen 1 (94-102) is a 9-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (94-102); Cancer / testis antigen 6.1 (94-102); L antigen family member 2 (94-102). | |
| Cancer / testis antigen 1 (95-107) | Cancer / testis antigen 1 (95-107) is a 13-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (95-107); Cancer / testis antigen 6.1 (95-107); L antigen family member 2 (95-107). | |
| Cancer / testis antigen 1 (96-104) | Cancer / testis antigen 1 (96-104) is a 9-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (96-104); Cancer / testis antigen 6.1 (96-104); L antigen family member 2 (96-104). | |
| Cancer / testis antigen 1 (ORF2 (14-33)) | Cancer / testis antigen 1 (ORF2 (14-33)) is a 20-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (ORF2 (14-33)); Cancer / testis antigen 6.1 (ORF2 (14-33)); L antigen family member 2 (ORF2 (14-33)). | |
| Cancer / testis antigen 1 (ORF2 (18-27)) | Cancer / testis antigen 1 (ORF2 (18-27)) is a 10-aa peptide. Cancer / testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Alternative Names: NY-ESO-1 (ORF2 (18-27)); Cancer / testis antigen 6.1 (ORF2 (18-27)); L antigen family member 2 (ORF2 (18-27)). | |
| Cancer / testis antigen 2 (103-111) | Cancer / testis antigen 2 (103-111) is amino acids 103 to 111 fragment of Cancer / testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Alternative Names: Autoimmunogenic cancer / testis antigen NY-ESO-2 (103-111); Cancer / testis antigen 6.2 (103-111); L antigen family member 1 (103-111). | |
| Cancer / testis antigen 2 (108-120) | Cancer / testis antigen 2 (108-120) is amino acids 108 to 120 fragment of Cancer / testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Alternative Names: Autoimmunogenic cancer / testis antigen NY-ESO-2 (108-120); Cancer / testis antigen 6.2 (108-120); L antigen family member 1 (108-120). | |
| Cancer / testis antigen 2 (37-50) | Cancer / testis antigen 2 (37-50) is amino acids 37 to 50 fragment of Cancer / testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Alternative Names: Autoimmunogenic cancer / testis antigen NY-ESO-2 (37-50); Cancer / testis antigen 6.2 (37-50); L antigen family member 1 (37-50). | |
| Cancer / testis antigen 2 (ORF2 (1-11)) | Cancer / testis antigen 2 (ORF2 (1-11)) is a bioactive peptide of Cancer / testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Alternative Names: Autoimmunogenic cancer / testis antigen NY-ESO-2 (ORF2 (1-11)); Cancer / testis antigen 6.2 (ORF2 (1-11)); L antigen family member 1 (ORF2 (1-11)). | |
| Candida Albicans alpha factor | Candida Albicans alpha factor. Alternative Names: Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly. Molecular formula: C72H97N17O19. Mole weight: 1504.70. | |
| Canine beta-defensin | Canine beta-defensin is isolated from Canis lupus familiaris. It has antibacterial and antifungal activity. | |
| Capistruin | Capistruin is isolated from Burkholderia thailandensis E264. It exhibits antimicrobial activity against closely related Burkholderia and Pseudomonas strains. | |
| Caprooyl Tetrapeptide-3 | Caprooyl Tetrapeptide-3 is a synthetically derived peptide that is used in skincare to help improve the visible signs of aging. It is known for its ability to stimulate the expression of collagen VII and laminin-5, which are crucial for maintaining the integrity of the dermal-epidermal junction (DEJ) and providing firmness to the skin. This peptide is also recognized for its potential to reduce the appearance of fine lines and wrinkles by enhancing the synthesis of these structural proteins. It is used for skin repair. Alternative Names: L-Lysinamide, N2-(1-oxohexyl)-L-lysylglycyl-L-histidyl-; N2-(1-Oxohexyl)-L-lysylglycyl-L-histidyl-L-lysinamide; Caprooyl-Lys-Gly-His-Lys-NH2; L-Lysyl-N-hexanoylglycyl-L-histidyl-L-lysinamide; N-Hexanoyl-L-lysyl-glycyl-L-histidyl-L-lysinamide; Hexanoyl-Lys-Gly-His-Lys-NH2; KGHK; (S)-6-Amino-N-(2-(((S)-1-(((S)-1,6-diamino-1-oxohexan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)-2-hexanamidohexanamide. Grades: ≥95%. CAS No. 1012317-70-2. Molecular formula: C26H47N9O5. Mole weight: 565.71. | |
| Captopril Impurity K | ACE-inhibitors. Alternative Names: (2S)-3-(Acetylthio)-2-methylpropanoic Acid; (S)-3-(Acetylthio)-2-methylpropanoic acid; (S)-3-Acetylsulfanyl-2-methylpropionic Acid; (S)-3-Acetylthio-2-methylpropionic acid; D-(-)-3-Acetylthio-2-methylpropionic Acid; D-3-Acetylthio-2-methylpropionic Acid. Grades: 98-100% (Assay by titration). CAS No. 76497-39-7. Molecular formula: C6H10O3S. Mole weight: 162.21. | |
| Carbobenzoxyhydrazide hydrochloride | Carbobenzoxyhydrazide hydrochloride. Alternative Names: Z-NHNH2 HCl; Z-hydrazide HCl; Benzyl carbazate hydrochloride. Grades: 95+%. CAS No. 2540-62-7. Molecular formula: C8H11ClN2O2. Mole weight: 202.64. | |
| Carbonic acid di-2-pyridyl ester | Carbonic acid di-2-pyridyl ester is used as a coupling agent in the esterification of carboxylic acids. Di-2-pyridyl carbonate is also used as a reagent to synthesize active carbonates and carbamates. Alternative Names: DPC; 2-Pyridinol-2,2'-carbonate; 2-Pyridinol Carbonate; Bis(pyrid-2-yl) Carbonate; Bis(pyridin-2-yl) Carbonate; Di-2-pyridyl Carbonate; 2-Pyridinol, carbonate (2:1) (ester) (9CI); Carbonic acid, di-2-pyridyl ester (7CI,8CI). Grades: 98 % (HPLC). CAS No. 1659-31-0. Molecular formula: C11H8N2O3. Mole weight: 216.19. | |
| Carbonic anhydrase 9 (254-262) | Carbonic anhydrase 9 (254-262) is a peptide corresponding to residues 254-262 of Carbonic anhydrase 9. Carbonic anhydrase 9 has been correlated with progression and survival in patients with renal cell carcinoma (RCC). Alternative Names: Carbonic anhydrase IX (254-262); CAIX (254-262). | |
| Carboxylic acid functionalized polyethyleneglycol resin, High Load | TentaGel resins are grafted copolymers consisting of a low crosslinked polystyrene matrix on which poly(ethylene glycol) (PEG or POE) is grafted. Alternative Names: COOH-PEG Resin, HL; TentaGel HL COOH; High loaded TentaGel carboxy resin. | |
| Carboxylic acid functionalized polyethyleneglycol resin (macro beads) | TentaGel resins are grafted copolymers consisting of a low crosslinked polystyrene matrix on which poly(ethylene glycol) (PEG or POE) is grafted. Alternative Names: COOH-PEG-Macro Resin; TentaGel MB COOH; Macrobead TentaGel carboxy resin. | |
| Carboxypolystyrene | Carboxypolystyrene can be used for the solid phase immobilization of amines, alcohols and phenols. Alternative Names: Polystyrene carboxylic acid. | |
| Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 | Diseases associated with CTDSP2 include Acute Tympanitis and Myringitis Bullosa Hemorrhagica. Among its related pathways are Signaling by BMP and Metabolism of proteins. Alternative Names: Nuclear LIM interactor-interacting factor 2. | |
| Carcinine | Carcinine, a natural peptide derivative, is a highly selective histamine H3 receptor antagonist. It has antioxidant and anti-saccharification functions and has better stability because it is not recognized by enzymes in the body and loses activity. It can be used to remove skin yellow, lighten skin tone, fight against the invasion of external ultraviolet rays and pollutants and other adverse environment on the skin, prevent skin premature aging, maintain skin young state, can be added to beauty care products, such as emulsion, mask, morning, night cream, eye cream, eye serum, facial essence, muscle base liquid, toner, eye mask, gel and so on. Alternative Names: Propanamide, 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]-; 3-Amino-N-[2-(1H-imidazol-4-yl)ethyl]propanamide; Alistin; Decarboxycarnosine; β-Alanylhistamine; Decarboxy Carnosine. Grades: ≥98% by HPLC. CAS No. 56897-53-1. Molecular formula: C8H14N4O. Mole weight: 182.22. | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (116-140) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (116-140); Cluster of Differentiation 66e (116-140). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (268-277) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (268-277); Cluster of Differentiation 66e (268-277). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (355-367) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (355-367); Cluster of Differentiation 66e (355-367). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (425-437) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (425-437); Cluster of Differentiation 66e (425-437). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (568-582) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (568-582); Cluster of Differentiation 66e (568-582). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (605-613) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (605-613); Cluster of Differentiation 66e (605-613). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (61-69) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (61-69); Cluster of Differentiation 66e (61-69). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (625-639) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (625-639); Cluster of Differentiation 66e (625-639). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (652-660) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (652-660); Cluster of Differentiation 66e (652-660). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (653-667) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (653-667); Cluster of Differentiation 66e (653-667). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (666-678) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (666-678); Cluster of Differentiation 66e (666-678). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (691-699) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (691-699); Cluster of Differentiation 66e (691-699). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (694-702) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (694-702); Cluster of Differentiation 66e (694-702). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (99-111) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Alternative Names: CEACAM5 (99-111); Cluster of Differentiation 66e (99-111). | |
| Cardiotoxin Analog (CTX) IV 6-12 | Cardiotoxin Analog (CTX) IV (6-12) is the 6-12 amino acid fragment of CTX IV, which is a unique snake venom cardiotoxin. Alternative Names: Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2; L-leucyl-L-isoleucyl-L-prolyl-L-prolyl-L-phenylalanyl-L-tryptophyl-L-lysinamide; Naja mossambica mossambica alpha-neurotoxin I. Grades: ≥95%. CAS No. 115722-23-1. Molecular formula: C48H70N10O7. Mole weight: 899.13. | |
| Cardiotoxin Analog (CTX) IV (6-12) TFA | Cardiotoxin Analog (CTX) IV (6-12) is the 6-12 amino acid fragment of CTX IV, which is a unique snake venom cardiotoxin. CAS No. 2918768-05-3. Molecular formula: C50H71F3N10O9. Mole weight: 1013.16. | |
| Carglumic Acid | Carglumic Acid is an activator of carbamoyl phosphate synthetase 1 (CPS1). It inhibits cell proliferation of a variety of cancer cell lines with IC50 values ranging from 5 to 7.5 nM. Alternative Names: N-Carbamyl-L-glutamic acid; (S)-2-ureidopentanedioic acid; Carbaglu; N-Carbamylglutamate; Ureidoglutaric acid; Carbamino-L-glutamic acid. Grades: 95%. CAS No. 1188-38-1. Molecular formula: C6H10N2O5. Mole weight: 190.15. | |
| Carnocyclin A | Carnocyclin A is a 60-amino acid circular bacteriocin produced by Carnobacterium maltaromaticum UAL307 that exhibits potent activity against many Gram-positive bacteria. Alternative Names: CclA. | |
Our database is helping our users find suppliers everyday.
